Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2012-04-17 Annual Report
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Jahresabschluss zum Geschäftsjahr vom 01.01.2010 bis zum 31.12.2010
Annual Report Classification · 1% confidence The document is a German 'Jahresabschluss' (Annual Financial Statement) for the fiscal year 2010, containing a balance sheet ('Bilanz'), notes ('Anhang'), and specific financial disclosures required by the German Commercial Code (HGB). It provides comprehensive financial data rather than just an announcement or summary. As it represents the full annual financial reporting for the company, it aligns with the definition of an Annual Report (10-K). FY 2010
2012-04-17 German
STRATEC posts record sales for 2011
Earnings Release Classification · 1% confidence The document text explicitly states: "STRATEC Biomedical AG... today announced its definitive results for the financial year ending on December 31, 2011 with the publication of its 2011 Annual Report." It then proceeds to detail the full year's financial performance (Sales, EBIT, Net Income, EPS) for the year ended December 31, 2011, including comparative figures for 2010. This content aligns perfectly with the definition of an Annual Report (10-K), which covers company activity and full financial performance for the year. Although it is an announcement of the results, the length (8061 chars) and the depth of the financial tables and discussion suggest it is the primary content of the Annual Report itself, rather than just a brief RPA announcement. The mention of the upcoming AGM and dividend proposal further supports this being the year-end financial disclosure. FY 2011
2012-03-28 English
Annual Report 2011
Annual Report Classification · 1% confidence The document is a comprehensive annual report for STRATEC Biomedical AG for the 2011 financial year. It contains the 'Report of the Board of Management', 'Report of the Supervisory Board', 'Group Management Report', and 'Consolidated Financial Statements'. It is clearly the full annual report, not an announcement or a summary, as it includes detailed financial and operational disclosures. FY 2011
2012-03-28 German
Report Publication Announcement 2012
Report Publication Announcement Classification · 1% confidence The document text is very short (1527 characters) and explicitly states that it is an 'Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG' regarding the disclosure of financial statements. It specifies the 'Annual financial report of the group' will be disclosed on 'March 28, 2012', and provides links to where the report will be available. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached classifies as a Report Publication Announcement (RPA), not the report itself (10-K).
2012-03-14 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification received from Allianz Global Investors Kapitalanlagegesellschaft mbH regarding their voting rights falling below the 3% threshold in STRATEC Biomedical AG, citing specific sections of the German Securities Trading Act (WpHG). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is short and is a direct announcement of a voting rights change, not a comprehensive report.
2012-02-24 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states in the header that it is a 'Voting Rights Announcement' and details changes in the share of voting rights held by Threadneedle Investment Funds ICVC and Threadneedle Investment Services Limited, referencing German Securities Trading Act (§ 21 sec. 1 WpHG). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is short and contains the core announcement, not an announcement about a separate report.
2012-01-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.